本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atara Biotherapeutics

9.24
-0.0100-0.11%
成交量:4.30萬
成交額:39.70萬
市值:9,274.83萬
市盈率:-7.77
高:9.88
開:9.21
低:8.92
收:9.25
52周最高:19.15
52周最低:3.92
股本:1,003.77萬
流通股本:462.30萬
量比:0.89
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-1.1889
每股收益(LYR):2.57
淨資產收益率:-2014.86%
總資產收益率:-24.14%
市淨率:-2.51
市盈率(LYR):3.60

資料載入中...

2026/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/02

重要事件披露

Form 8-K - Current report
2026/03/24

SEC問詢函

Form CORRESP - Correspondence
2026/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/17

重要事件披露

Form 8-K - Current report